Skip to main content
. 2015 Jul 31;10(4):2185–2191. doi: 10.3892/ol.2015.3556

Figure 2.

Figure 2.

Kaplan-Meier method analysis of biochemical recurrence-free survival for prostate cancer patients. Correlations between: (A) MT-2A expression and biochemical recurrence-free survival (P=0.022); (B) E-cadherin expression and PSA biochemical recurrence-free survival (P=0.028); (C) IL-6 expression and biochemical recurrence-free survival (P=0.072); (D) cyclin E expression and biochemical recurrence-free survival (P=0.011); (E) PCNA expression and biochemical recurrence-free survival (P=0.091); and (F) Bcl-2 expression and biochemical recurrence-free survival (P=0.136). MT-2A, metallothionein-2A; IL-6, interleukin 6; PCNA, proliferating cell nuclear antigen; Bcl-2, B cell lymphoma 2.